Pharmacoinduced effects in the oral cavity.
DOI:
https://doi.org/10.35954/SM1998.20.1.12Keywords:
Oral Cavity; Mucosal Injuries; Drugs/Injurious Actions; Dentistry.Abstract
The group of Pharmacy-induced effects in the oral cavity is analysed by checking the drugs action in different oral structures (mucous membrane, teeth, salivary gland, neuromuscular system, gustatory system and pre-malignity manifestations, pseudo-malignity and malignity associated with drugs) supporting the diagnosis and prognosis interest. A revision on the present status of the adverse drugs effects on the oral cavity sustains the interest of these lesions, considering a) its great clinical polymorphism (to the extreme of comprising the entire scope of elementary lesions in mucous membrane and hard dental tissues) and b) the great diversity of drug agents which are able to generate them, to the extent of sustaining the affirmation of Mc Carthy: ‘any drug is able to cause any type of reaction".
Downloads
References
(1) BAKER KA, ETTINGER RL. Intrea-oral effects of drugs in eldearly persons. Gerodontics 1:111, 1985.
(2) BAUM BJ. Evaluation of stimulate parotid saliva flow rate in different age groups. J Dent Res. 60:1292,1981
(3) CLINICAS ODONTOLOGICAS DE NORTEAMÉ- RICA. Vol 4/1994 Farmacodontología. 742-759.
(4) Clínicas Odont. de Norteamérica. Volumen 3/1984 Farmacología y terapéutica.
(5) Council on Dental Materials, Instruments, and Equipment. American Dental Association status report on the ocurrence of galvanic coorotion in the mouth and its potential effects. J Am Dent Assoc 115:783,1987.
(6) COLT HG, SHAPIRO AP. Drug induced ilness as a cause for admission to a community hospital. J Am Geriatr Soc 37:323,1989.
(7) CHIODO GT, ROSESTEIN DI. Tardive dyskinesia Gen Dent 38:289,1990.
(8) DEEMS DA, DOTY RL, SETTLE RG. Smell and taste disordears. A study of 750 patients from University of Pennylvania Smell ans Taste Cen-ter. Arch Otolaryngol Head and Neck Surgery 117- 519,1991.
(9) GORSKY DMD, SILMERMAN SR, CHINN H. Clinical charetrestics and management outcome in the burning mouth syndrome.Oral Surgery 72:192,1991.
(10) GRINSPAN,DAVID. Enfermedades de la encía. 1739:1771. Enfermedades de la boca. Editorial Mundi.1975.
(11) GRINSPAN, DAVID. Intoxicacions crónicas. 1283:1299. Enfermedades de la boca. Editorial Mundi 1975.
(12) HESPO HU, BJORNLAND T. Side effects and patient accptance of 0,2% versus 0,1% clorhxidine used as psdt-operative mouthwash.Oral Maxillofac Surg 17:17 1988.
(13) LASKARIS, GEORGE. Oral Diseases. Efeccts drugs induced. 68.79.1994.
(14) Neville. Damm.Oral y maxillofac. Pathology De. Saunders. 1995.
(15) Oral and Maxillofacial Surgery Clinics of North America.August 1994.Vol 6 Number 3.
(16) PERSSON RE, IZUTSU KT. Differences in salivary flow rates in elderly subjects using xerostomatic medications Oral Surg Oral Med Oral Pathol. 72:42 1991.
(17) PINDBORG. Masson-Salvat. Enfermedades de la mucosa oral. 324:344, 1992.
(18) SHARAV Y, SINGER E. The analgesic effect of amitrptuline on chronic facial pain. Pin 31:1999, 1987.
(19) SALTZ BL, WOERNER MG. Prospetivy study of tardiva dyskenesia incidence in the eaderly. JAMA 81:115, 1991.
(20) SHKLAR MC CARTHY. Enfermedades de la mucosa oral. 1995.
(21) STASSBURG M. Diseases of the oral mucosa. Quintessence Publishing Co. Chapter 31; 671:712, 1994.
(22) SINGER E. Pain control in dentistry. Management of chronic oro facial pain. 8: 114, 1987.
(23) SIEGEL MA. Medication can induce severe ulcerations. J Am Assoc 22:75, 1991.
(24) SHAFER WG, HINE MK, LEVI BM. Texbook of Oral Pathology. Saunders 583:584, 1983.
(25) SKIEMORE-ROTH MOSBYS 1992. Nursing Drug Reference. Year-Book 83, 1992.
(26) YONTCHEV E, HEDEGARD B. Preported symptoms, diseases and medications of patients with orofacial discomfort complaints. J Oral Maxillofac Surg 15:35, 1986.
(27) ZISKIN DE, MOULTON R. Glossodynia A Study of orolingula pain. J Am Dent Assoc 33:1423.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
